SCHEMBL6708924

SCHEMBL6708924

N#Cc1ccc(NC(=O)c2cc3cccc(NC(=O)Cc4cccc5ccccc45)c3[nH]2)c(-c2nnn[nH]2)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.41
PARP14 Q460N5 1/20 0.40
MEN1 O00255 4/20 0.38
KMT2A Q03164 4/20 0.38
KDM4E B2RXH2 1/20 0.38
LMNA P02545 1/20 0.38
HPGD P15428 1/20 0.38
PTGER4 P35408 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
MAPK8 P45983 5/20 0.38
MAPK10 P53779 5/20 0.38
MAPK9 P45984 4/20 0.38
POLB P06746 1/20 0.36
HDAC3 O15379 1/20 0.36
HDAC1 Q13547 1/20 0.36
HDAC8 Q9BY41 1/20 0.36
CCNA2 P20248 1/20 0.36
CDK2 P24941 1/20 0.36
CCNA1 P78396 1/20 0.36
RAB9A P51151 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6711981 0.92 ALDH1A1 (0.39) ALDH1A1PARP14MEN1KMT2AKDM4E
SCHEMBL6708617 0.92 PARP14 (0.41) ALDH1A1PARP14KDM4ELMNAHPGD
SCHEMBL6711390 0.90 TP53 (0.42) ALDH1A1MEN1KMT2AKDM4ELMNA
SCHEMBL6711927 0.90 PARP14 (0.44) PARP14LMNAPOLB
SCHEMBL6713331 0.90 PARP14 (0.38) ALDH1A1PARP14SMN1; SMN2MAPK8MAPK10
SCHEMBL6712123 0.90 PLA2G7 (0.35) ALDH1A1PARP14MEN1KMT2AHPGD
SCHEMBL6710173 0.88 KMT2A (0.47) ALDH1A1PARP14MEN1KMT2AKDM4E
SCHEMBL6707757 0.88 KMT2A (0.49) ALDH1A1MEN1KMT2AKDM4ELMNA
SCHEMBL6916001 0.88 PARP14 (0.42) PARP14MEN1KMT2ALMNAPOLB
SCHEMBL6708920 0.88 PARP14 (0.42) PARP14MEN1KMT2ALMNAMAPK8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040142981-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-07-22 US disclosed
WO-2004018461-A2 ANTIBACTERIAL BENZOIC ACID DERIVATIVES PHARMACIA & UPJOHN COMPANY LLC (US) 2004-03-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040142981-A1 Antibacterial benzoic acid derivatives GABRD, PHB1, GABBR1 ALDH1A1 123/4885PARP14 2597/4885MEN1 4100/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.